Hypothesis

Senescent fibroblasts act as metabolic gatekeepers that toggle their secretory phenotype based on local NAD+ availability; high NAD+ shifts SASP from a cell‑cycle‑arresting, pro‑fibrotic state to a regenerative, pro‑angiogenic state, whereas NAD+ depletion locks them into a chronic, detrimental SASP.

Mechanistic Basis

• Senescent fibroblasts upregulate CD38, a NAD+-consuming enzyme, as part of the SASP 1. Elevated CD38 activity depletes NAD+, inhibiting SIRT1 and SIRT3 activity, which in turn stabilizes p53/p21 signaling and reinforces a SASP rich in TGF‑β, PAI‑1, and IL‑6—factors that enforce growth arrest and promote extracellular‑matrix deposition.
• Conversely, when NAD+ levels rise (e.g., via fasting, ketosis, or NAD+ precursors), SIRT1 deacetylates NF‑κB, reducing transcription of classic proinflammatory SASP components while enhancing FOXO‑driven expression of regenerative factors such as VEGF‑A, HGF, and MMP‑14. SIRT3 activation improves mitochondrial ROS handling, lowering oxidative stress‑induced SASP amplification.
• This creates a bistable switch: NAD+ high → SIRT‑active → regenerative SASP; NAD+ low → CD38‑high → arrest/fibrotic SASP. The switch is reinforced by autocrine loops where SASP‑derived exosomes deliver miR‑34a (inhibits SIRT1) or miR‑21 (targets SIRT3) depending on the metabolic state.

Predictions & Experimental Design

1. Pharmacological CD38 inhibition in aged mice will restore a regenerative SASP without clearing senescent cells.
   • Treat old mice with a CD38 antagonist (e.g., 78c) or NAD+ booster (NR) for two weeks.
   • Measure SASP composition in skin wound edge fibroblasts via ELISA and single‑cell RNA‑seq.
   • Predict: reduced TGF‑β/PAI‑1, increased VEGF‑A/HGF; accelerated wound closure comparable to young controls.
2. NAD+ depletion in young mice will convert transiently beneficial senescent fibroblasts into a chronic, fibrotic SASP.
   • Induce local NAD+ reduction using FK866 (NAMPT inhibitor) in young mice after creating senescent fibroblasts via irradiation.
   • Assess SASP shift and collagen deposition at day 7 and day 14 post‑injury.
   • Predict: early rise in TGF‑β and collagen I, delayed re‑epithelialization.
3. Exosome transfer from NAD+‑high senescent fibroblasts will rescue proliferation of neighboring stem cells.
   • Isolate exosomes from fibroblasts treated with NR vs. vehicle, label with PKH67, and apply to epithelial stem cell cultures.
   • Measure Ki‑67 and colony‑forming efficiency.
   • Predict: exosomes from NAD+‑high condition increase stem cell proliferation; effect blocked by SIRT1 inhibitor.

Potential Implications

If validated, this hypothesis reframes senolytics not as a blanket removal strategy but as a context‑dependent modulation of senescent cell metabolic state. It suggests that metabolic interventions (fasting, ketosis, NAD+ boosters) could preserve the beneficial "hostage negotiator" phase of senescence while preventing its transition to a chronic, tissue‑destructive state. Such an approach may improve regenerative outcomes in aged or diabetic wounds without the risks associated with indiscriminate senescent cell ablation.